$14.22
-0.15[-1.04%]
Last update: 1:21PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$14.39
0.1700[1.20%]
| Open14.390 | Close- |
| Vol / Avg.132.094K / 534.260K | Mkt Cap499.339M |
| Day Range14.195 - 14.520 | 52 Wk Range7.640 - 28.250 |
Harrow Health Stock (NASDAQ:HROW), Key Statistics
Harrow Health Stock (NASDAQ: HROW) analysis, key statistics.
Valuation Measures
Enterprise Value
652.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.06
Price / Book (mrq)
22.52
Price / EBITDA
29.57
Enterprise Value / EBITDA (TTM)
46.27
Earnings Yield
-3.83%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
-3.71
Total Liabilities (Quarterly)
201.9M
Total Assets
224M
Total Liabilities
201.9M
Profitability
Net income Growth
- -
Gross Margin
70.12%
Net Margin
-12.64%
EBIT Margin
4.36%
EBITDA Margin
14.58%
Operating Margin
7.03%
Harrow Health Stock (NASDAQ:HROW), Key Statistics
Harrow Health Stock (NASDAQ: HROW) analysis, key statistics.
Valuation Measures
Enterprise Value
652.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.06
Price / Book (mrq)
22.52
Price / EBITDA
29.57
Enterprise Value / EBITDA (TTM)
46.27
Earnings Yield
-3.83%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
-3.71
Total Liabilities (Quarterly)
201.9M
Total Assets
224M
Total Liabilities
201.9M
Profitability
Net income Growth
- -
Gross Margin
70.12%
Net Margin
-12.64%
EBIT Margin
4.36%
EBITDA Margin
14.58%
Operating Margin
7.03%
Harrow Health Stock (NASDAQ:HROW), Key Statistics
Harrow Health Stock (NASDAQ: HROW) analysis, key statistics.
Valuation Measures
Enterprise Value
652.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.06
Price / Book (mrq)
22.52
Price / EBITDA
29.57
Enterprise Value / EBITDA (TTM)
46.27
Earnings Yield
-3.83%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
-3.71
Total Liabilities (Quarterly)
201.9M
Total Assets
224M
Total Liabilities
201.9M
Profitability
Net income Growth
- -
Gross Margin
70.12%
Net Margin
-12.64%
EBIT Margin
4.36%
EBITDA Margin
14.58%
Operating Margin
7.03%
Harrow Health Stock (NASDAQ:HROW), Key Statistics
Harrow Health Stock (NASDAQ: HROW) analysis, key statistics.
Valuation Measures
Enterprise Value
652.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.06
Price / Book (mrq)
22.52
Price / EBITDA
29.57
Enterprise Value / EBITDA (TTM)
46.27
Earnings Yield
-3.83%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
-3.71
Total Liabilities (Quarterly)
201.9M
Total Assets
224M
Total Liabilities
201.9M
Profitability
Net income Growth
- -
Gross Margin
70.12%
Net Margin
-12.64%
EBIT Margin
4.36%
EBITDA Margin
14.58%
Operating Margin
7.03%
Harrow Health Stock (NASDAQ:HROW), Key Statistics
Harrow Health Stock (NASDAQ: HROW) analysis, key statistics.
Valuation Measures
Enterprise Value
652.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.06
Price / Book (mrq)
22.52
Price / EBITDA
29.57
Enterprise Value / EBITDA (TTM)
46.27
Earnings Yield
-3.83%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
-3.71
Total Liabilities (Quarterly)
201.9M
Total Assets
224M
Total Liabilities
201.9M
Profitability
Net income Growth
- -
Gross Margin
70.12%
Net Margin
-12.64%
EBIT Margin
4.36%
EBITDA Margin
14.58%
Operating Margin
7.03%
Harrow Health Stock (NASDAQ:HROW), Key Statistics
Harrow Health Stock (NASDAQ: HROW) analysis, key statistics.
Valuation Measures
Enterprise Value
652.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.06
Price / Book (mrq)
22.52
Price / EBITDA
29.57
Enterprise Value / EBITDA (TTM)
46.27
Earnings Yield
-3.83%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
-3.71
Total Liabilities (Quarterly)
201.9M
Total Assets
224M
Total Liabilities
201.9M
Profitability
Net income Growth
- -
Gross Margin
70.12%
Net Margin
-12.64%
EBIT Margin
4.36%
EBITDA Margin
14.58%
Operating Margin
7.03%
Harrow Health Stock (NASDAQ:HROW), Key Statistics
Harrow Health Stock (NASDAQ: HROW) analysis, key statistics.
Valuation Measures
Enterprise Value
652.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.06
Price / Book (mrq)
22.52
Price / EBITDA
29.57
Enterprise Value / EBITDA (TTM)
46.27
Earnings Yield
-3.83%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
-3.71
Total Liabilities (Quarterly)
201.9M
Total Assets
224M
Total Liabilities
201.9M
Profitability
Net income Growth
- -
Gross Margin
70.12%
Net Margin
-12.64%
EBIT Margin
4.36%
EBITDA Margin
14.58%
Operating Margin
7.03%
Harrow Health Stock (NASDAQ:HROW), Key Statistics
Harrow Health Stock (NASDAQ: HROW) analysis, key statistics.
Valuation Measures
Enterprise Value
652.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.06
Price / Book (mrq)
22.52
Price / EBITDA
29.57
Enterprise Value / EBITDA (TTM)
46.27
Earnings Yield
-3.83%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
-3.71
Total Liabilities (Quarterly)
201.9M
Total Assets
224M
Total Liabilities
201.9M
Profitability
Net income Growth
- -
Gross Margin
70.12%
Net Margin
-12.64%
EBIT Margin
4.36%
EBITDA Margin
14.58%
Operating Margin
7.03%
Harrow Health Stock (NASDAQ:HROW), Key Statistics
Harrow Health Stock (NASDAQ: HROW) analysis, key statistics.
Valuation Measures
Enterprise Value
652.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
4.06
Price / Book (mrq)
22.52
Price / EBITDA
29.57
Enterprise Value / EBITDA (TTM)
46.27
Earnings Yield
-3.83%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.64
Tangible Book value per share
-3.71
Total Liabilities (Quarterly)
201.9M
Total Assets
224M
Total Liabilities
201.9M
Profitability
Net income Growth
- -
Gross Margin
70.12%
Net Margin
-12.64%
EBIT Margin
4.36%
EBITDA Margin
14.58%
Operating Margin
7.03%